ロード中...
Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer
BACKGROUND: The luminal subtype of breast cancer is sensitive to anti-estrogen therapy and shows a better prognosis than that of human epidermal growth factor receptor2 (HER2)-enriched or triple-negative breast cancer. However, the luminal type of breast cancer is heterogeneous and can have aggressi...
保存先:
| 出版年: | World J Surg Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5020449/ https://ncbi.nlm.nih.gov/pubmed/27619909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-016-0999-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|